Filing Details
- Accession Number:
- 0001127602-13-008468
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-28 11:22:37
- Reporting Period:
- 2013-02-27
- Filing Date:
- 2013-02-28
- Accepted Time:
- 2013-02-28 11:22:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190841 | Peter Soltani | 35 Crosby Drive Bedford MA 01730 | Svp & Gm, Women's Health | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-02-27 | 32,000 | $14.50 | 88,704 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-27 | 32,000 | $22.05 | 56,704 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-02-27 | 12,000 | $13.63 | 68,704 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-27 | 12,000 | $22.02 | 56,704 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-02-27 | 24,729 | $15.75 | 81,433 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-27 | 24,729 | $22.05 | 56,704 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-02-27 | 20,000 | $13.87 | 76,704 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-27 | 20,000 | $22.05 | 56,704 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2013-02-27 | 32,000 | $0.00 | 32,000 | $14.50 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2013-02-27 | 12,000 | $0.00 | 12,000 | $13.63 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2013-02-27 | 24,729 | $0.00 | 24,729 | $15.75 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2013-02-27 | 20,000 | $0.00 | 20,000 | $13.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
8,000 | 2015-11-13 | No | 4 | M | Direct | |
8,000 | 2016-06-22 | No | 4 | M | Direct | |
16,486 | 2016-11-11 | No | 4 | M | Direct | |
0 | 2006-10-31 | 2015-10-31 | No | 4 | M | Direct |
Footnotes
- The transaction reported herein reflects an aggregate of sales at prices ranging from $22.01 to $22.085, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.
- The transaction reported herein reflects an aggregate of sales at prices ranging from $22.01 to $22.06, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.
- The transaction reported herein reflects an aggregate of sales at prices ranging from $21.99 to $22.16, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.
- The transaction reported herein reflects an aggregate of sales at prices ranging from $21.99 to $22.152, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.
- The option becomes exercisable in five equal annual installments beginning November 13, 2009
- The option becomes exercisable in five equal annual installments beginning June 22, 2010.
- The option, issued pursuant to the 2008 Equity Incentive Plan, becomes exercisable in five equal annual installments beginning November 11, 2010.